MEDS's free cash flow for Q was $-386.35K. For the fiscal year, MEDS's free cash flow was decreased by $-89.50K and operating cash flow was $-386.35K. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Operating Cash Flow	$ -1.59M	$ -1.59M	$ -1.53M	$ -2.57M	$ -2.21M	$ 141.78K
Investing Cash Flow	$ -344.45K	$ -344.45K	$ -427.85K	$ -22.60K	$ -37.51K	$ -332.25K
Financing Cash Flow	$ 1.91M	$ 1.91M	$ -35.17K	$ -208.18K	$ 5.30M	$ 2.19M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 2.26M	$ 151.91K	$ 1.13M	$ 3.12M	$ 5.92M	$ 2.87M
Income Tax Paid Supplemental Data	-	-	-	-	$ 0.00	$ 0.00
Interest Paid Supplemental Data	$ 733.69K	$ 733.69K	$ 336.21K	$ 28.34K	$ 29.44K	$ -98.46K
Issuance Of Capital Stock	-	-	$ 130.92K	-	$ 5.99M	$ 2.46M
Issuance Of Debt	$ 250.00K	$ 250.00K	-	$ -225.00K	-	-
Repayment Of Debt	$ -150.00K	$ -150.00K	-	$ -225.00K	$ 0.00	$ -262.55K
Free Cash Flow	$ -1.92M	$ -1.59M	$ -1.50M	$ -2.59M	$ -2.25M	$ 59.52K
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Trxade Group Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing